Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer

Nuclear Medicine and Biology

Volumn 35, Issue 5, 2008, Pages 589-597

  Chakraborty, Sudipta ^a   Das, Tapas ^a   Sarma, Haladhar D ^a   Venkatesh, Meera ^a   Banerjee, Sharmila ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

177Lu; Hydroxyapatite; Intra arterial radionuclide therapy; Liver cancer; Radiolabeled microspheres particulates

Indexed keywords

HYDROXYAPATITE; LUTETIUM 177; RADIOISOTOPE;

ANIMAL EXPERIMENT; ARTICLE; CANCER THERAPY; DRUG UPTAKE; GAMMA SPECTROMETRY; HALF LIFE TIME; HEPATIC ARTERY; ISOTOPE LABELING; LIVER CELL CARCINOMA; NONHUMAN; PARTICLE SIZE; POWDER; RADIOCHEMISTRY; RAT; SCINTILLATION CAMERA; SYNTHESIS; TISSUE DISTRIBUTION; X RAY DIFFRACTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; DRUG STABILITY; DURAPATITE; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOTOPE LABELING; LIVER NEOPLASMS; LUTETIUM; NANOPARTICLES; PARTICLE SIZE; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; WHOLE-BODY COUNTING; X-RAY DIFFRACTION;

EID: 45449103656     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.03.003     Document Type: Article

References (36)

1. Parkin M.D., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
2. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study. Eur J Nucl Med Mol Imaging 33 (2006) 344-352
3. Nijsen J.F.W., van het Schip A.D., Hennink W.E., Rook D.W., van Rijk P.P., and de Klerk J.M.H. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumors. Curr Med Chem 9 (2002) 73-82
4. Nijsen J.F.W., Jonnenberg B.A., Woittiez J.R.W., Rook D.W., Swildens-van Woudenberg I.A., van Rijk P.P., et al. Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: effects of preparation and neutron activation techniques. Eur J Nucl Med 26 (1999) 699-704
5. Cady B. Natural history of primary and secondary tumors of the liver. Semin Oncl 10 (1983) 127-135
6. 188Re) glass microspheres. Int J Radiat Oncl Biol Phys 44 (1999) 189-199
7. Farmer D.G., and Basuttil R.W. The role of multimodal therapy in the treatment of hepatocellular carcinoma. Cancer 73 (1994) 2669-2670
8. Nijsen F., Rook D., Brandt C., Meijer R., Dullens H., Jonnenberg B.A., et al. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med 28 (2001) 743-749
9. Meade V.M., Burton M.A., Gray B.N., and Self G.W. Distribution of different sized microspheres in experimental hepatic tumours. Eur J Cancer Clin Oncl 23 (1987) 37-41
10. Anderson J.H., Angerson W.J., Willmott N., Kerr D.J., McArdle C.S., and Cooke T.G. Regional delivery of microspheres to liver metastases: the effect of particle size and concentration on intrahepatic distribution. Br J Cancer 64 (1991) 1031-1034
11. Leung W.T., Lau W.Y., Ho S., Chan M., Leung N., Lin J., et al. Selective internal radiation therapy with intra-arterial iodine-131-lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 35 (1994) 1313-1318
12. Ackerman N.B., Lien W.M., Kondi E.S., and Silverman N.A. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumours. Surgery 66 (1969) 1067-1072
13. Vente M.A.D., Hobbelink M.G.G., van het Schip A.D., Zonnenberg B.A., and Nijsen J.F.W. Radionuclide liver cancer therapy: from concept to current clinical status. Anti-Cancer Agents in Med Chem 7 (2007) 441-459
14. Lambert B., and Van de Wiele C. Treatment of hepatocellular carcinoma by means of radiopharmaceuticals. Eur J Nucl Med Mol Imaging 32 (2005) 980-989
15. 177Lu for radionuclide therapy. Appl Radiat Isot 59 (2003) 109-118
16. Ehrhardt G.J., and Day D.E. Therapeutic use of Y-90 microsphere. Int J Radiat Appl Instrum Part B Nucl Med Biol 14 (1987) 233-242
17. 90Y SIR-spheres: an evaluation with PET. Hepato-gastroenterol 54 (2007) 910-912
18. Mumper R.J., Ryo U.Y., and Jay M. Neutron activated holmium-166-poly (l-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumours. J Nucl Med 32 (1991) 2139-2143
19. Chinol M., Vallabhajosula S., Goldsmith S.J., Klein M.J., Deutsch K.F., Chinen L.K., et al. Chemistry and biological behaviour of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med 34 (1993) 1536-1542
20. 166Ho labeled hydroxyapatite (HA) particles for radiosynovectomy. Nucl Med Biol 29 (2002) 199-209
21. Clunie G., Lui D., Cullum I., Edwards J.C.W., and Ell P.J. Samarium-153-particulate hydroxyapatite for radiation synovectomy: biodistribution data for chronic knee synovitis. J Nucl Med 36 (1995) 51-57
22. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints. Nucl Med Biol 33 (2006) 585-591
23. 177Lu labeled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nucl Med Commun 27 (2006) 661-668
24. 166Ho-HA particles for radiation synovectomy. Ind J Nucl Med 15 (2000) 132 [abstract]
25. Kleinberg J. Inorganic synthesis vol VII (1988), Tata McGraw Hill Book Co. Inc., New York 63-64
26. Awasthi V., Meinken G., Springer K., Srivastava S.C., and Freimuth P. Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice. J Virol 78 (2004) 6431-6438
27. Panagi Z., Beletsi A., Evangelatos G., Livaniou E., Jthakissos D.S., and Avagoustakis K. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm 221 (2001) 143-152
28. 177Lu labeled metronidazole for possible use in targeting tumor hypoxia. Radiochim Acta 94 (2006) 375-380
29. 188Re generators. Appl Radiat Isot 45 (1994) 1123-1128
30. 90Y suitable for targeted therapy. Nucl Med Biol 35 (2008) 245-253
31. Raoul J.L., Bourguet P., Bretangne J.F., Duvauferrier R., Coornaert S., Darnault P., et al. Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 168 (1988) 541-545
32. 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Nucl Med Commun 23 (2002) 237-242
33. 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model. J Nucl Med 44 (2003) 2033-2038
34. Andrews J.C., Walker S.C., Ackermann R.J., Cotton L.A., Ensminger W.B., and Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35 (1994) 1637-1644
35. 166Ho-microsphere liver radiotherapy: a preclinical SPECT dosimetry study in the pig. Nucl Med Commun 15 (1994) 545-553
36. Conzone S.D., Hafeli U.O., Day D.E., and Ehrhardt G.J. Preparation and properties of rhenium glass microspheres intended for in-vivo radioembolization therapy. J Biomed Mater Res 42 (1998) 617-625